Cargando…

PD-L1 and the Clinical Outcomes of Ovarian Cancer: Meta-Analysis and Bioinformatical Analysis

OBJECTIVE: A meta-analysis was performed to analyze the association between PD-L1 expression and overall survival (OS) in various tumors and to identify potential targets through biological information analysis. METHODS: the data were collected from PubMed and Cochrane library, the all analysis of o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Xiaoling, Yun, Liu, Liu, Liu Chaoqun, Ding, Hui, Liang, Dan, Geng, Fang, Yu, Haiying, Ban, Jinxiu, Li, Jiajing, Jiang, Tao, Sun, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727364/ https://www.ncbi.nlm.nih.gov/pubmed/35901333 http://dx.doi.org/10.31557/APJCP.2022.23.7.2285

Ejemplares similares

Comparative Efficacy and Safety of Anti-PD-1/PD-L1 for the Treatment of Non-Small Cell Lung Cancer: A Network Meta-Analysis of 13 Randomized Controlled Studies
por: Jiang, Maofen, et al.
Publicado: (2022)

PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study
por: Jin, Liu, et al.
Publicado: (2020)

Identification of Key Candidate Genes and Pathways for Relationship between Ovarian Cancer and Diabetes Mellitus Using Bioinformatical Analysis
por: Sun, Yi, et al.
Publicado: (2019)

Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study
por: Wang, Lin
Publicado: (2019)

Expression Profile Analysis of Circular RNAs in Ovarian Endometriosis by Microarray and Bioinformatics
por: Zhang, Mengmeng, et al.
Publicado: (2018)

Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis
por: Wang, Qianqian, et al.
Publicado: (2017)

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis
por: Zeng, Siyuan, et al.
Publicado: (2023)

A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer
por: Zhu, Huijun, et al.
Publicado: (2021)

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Huang, Zi-Lu, et al.
Publicado: (2019)

PD‐1/PD‐L1 based immunochemotherapy versus chemotherapy alone for advanced esophageal squamous cell carcinoma: A meta‐analysis focus on PD‐L1 expression level
por: Jin, Zixian, et al.
Publicado: (2023)

Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis
por: Zhu, Jue, et al.
Publicado: (2021)

The efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysis
por: Yang, Yufan, et al.
Publicado: (2016)

Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
por: Liu, Haoran, et al.
Publicado: (2020)

Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer
por: Xue, Chunyan, et al.
Publicado: (2019)

OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
por: Shao, Yang, et al.
Publicado: (2021)

Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis
por: Zhang, Ke, et al.
Publicado: (2018)

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
por: Yang, Dan, et al.
Publicado: (2020)

Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence
por: Cui, Lixuan, et al.
Publicado: (2022)

Prognostic value of lactate dehydrogenase for melanoma patients receiving anti-PD-1/PD-L1 therapy: A meta-analysis
por: Xu, Jun, et al.
Publicado: (2021)

Platelets Increase the Expression of PD-L1 in Ovarian Cancer
por: Cho, Min Soon, et al.
Publicado: (2022)

Bioinformatics analysis to screen the key prognostic genes in ovarian cancer
por: Li, Li, et al.
Publicado: (2017)

PD-1 Coexpression Gene Analysis and the Regulatory Network in Endometrial Cancer Based on Bioinformatics Analysis
por: Wang, Lina, et al.
Publicado: (2021)

The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis
por: Liu, Cheng-Fei, et al.
Publicado: (2014)

Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
por: Liu, Surui, et al.
Publicado: (2022)

The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis
por: Chen, Xiao-Jiang, et al.
Publicado: (2020)

Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
por: Xu, Li, et al.
Publicado: (2022)

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
por: Chen, Shixue, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis
por: Wang, Shuxia, et al.
Publicado: (2020)

PD-1/PD-L1 immune checkpoint inhibitors in metastatic triple-negative breast cancer: a systematic review and meta-analysis
por: Yu, Yinan, et al.
Publicado: (2023)

Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
por: Shen, Xian, et al.
Publicado: (2018)

Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis
por: Liu, Junqi, et al.
Publicado: (2018)

Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer
por: Zhang, Yuedi, et al.
Publicado: (2022)

Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis
por: Tian, Yuan, et al.
Publicado: (2022)

Bioinformatics Analysis of Key Genes and Pathways of Cervical Cancer
por: Chen, Huan, et al.
Publicado: (2020)

Identification of Genes and Pathways Involved in Ovarian Epithelial Cancer by Bioinformatics Analysis
por: Zhou, Yun, et al.
Publicado: (2018)

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
por: Drakes, Maureen L., et al.
Publicado: (2018)

PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis
por: He, Runzhi, et al.
Publicado: (2022)

The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets
por: Shu, Qiang, et al.
Publicado: (2022)

Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges
por: Yang, Fang, et al.
Publicado: (2021)

The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis
por: Zeng, Yi-Fan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qvqodt8q5m0ao6rmpmgb519sd3